Drugs Approved for Colon and Rectal Cancer

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for colon and rectal cancer. The list includes generic and brand names. This page also lists common drug combinations used in colon and rectal cancer. The individual drugs in the combinations are FDA-approved. However, the drug combinations themselves usually are not approved, although they are widely used.

The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in colon cancer and rectal cancer that are not listed here.

On this page:

• Drugs Approved for Colon Cancer
• Drugs Approved for Rectal Cancer

Drugs Approved for Colon Cancer

Adrucil (Fluorouracil)
Avastin (Bevacizumab)
Bevacizumab
Camptosar (Irinotecan Hydrochloride)
Capecitabine
Cetuximab
Efudex (Fluorouracil)
Eloxatin (Oxaliplatin)
Erbitux (Cetuximab)
Fluoroplex (Fluorouracil)
Fluorouracil
Irinotecan Hydrochloride
Leucovorin Calcium
Oxaliplatin
Panitumumab
Vectibix (Panitumumab)
Wellcovorin (Leucovorin Calcium)
Xeloda (Capecitabine)

Drug Combinations Used in Colon Cancer

FOLFIRI 
FOLFIRI-BEVACIZUMAB
FOLFOX

Drugs Approved for Rectal Cancer

Adrucil (Fluorouracil)
Avastin (Bevacizumab)
Bevacizumab
Camptosar (Irinotecan Hydrochloride)
Cetuximab
Efudex (Fluorouracil)
Erbitux (Cetuximab)
Fluoroplex (Fluorouracil)
Fluorouracil
Irinotecan Hydrochloride
Panitumumab
Vectibix (Panitumumab)

Drug Combinations Used in Rectal Cancer

FOLFIRI
FOLFIRI-BEVACIZUMAB
FOLFOX

Back to Top